-+ 0.00%
-+ 0.00%
-+ 0.00%

Jefferies Maintains Buy on aTyr Pharma, Raises Price Target to $17

Benzinga·08/22/2025 17:40:33
Listen to the news
Jefferies analyst Roger Song maintains aTyr Pharma (NASDAQ:ATYR) with a Buy and raises the price target from $9 to $17.